Responsiveness of lower airways in adult patients (18-60 Years) with stable asthma after treatment with ciclesonide and fluticasone propionate (BY9010/NL-101)

Study identifier:BY9010/NL-101

ClinicalTrials.gov identifier:NCT00306163

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Nebulizer Trial: Evaluation of the influence of particle size of aerosolized AMP on bronchial responsiveness in patients with asthma and the effects of treatment with ciclesonide versus fluticasone.

Medical condition

asthma

Phase

Phase 3

Healthy volunteers

No

Study drug

Ciclesonide, Fluticasone

Sex

All

Actual Enrollment

37

Study type

Interventional

Age

18 Years - 60 Years

Date

Study Start Date: 01 May 2006
Primary Completion Date: 01 Aug 2008
Study Completion Date: 01 Sept 2008

Study design

Allocation: Randomized
Endpoint Classification: None
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Sept 2016 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria